Temsirolimus in Daily Use: Results of a Prospective Multicentre Noninterventional Study of Patients with Metastatic Kidney Cancer
Andres Jan Schrader(Universität Ulm), Thomas Steiner(Helios Klinikum Erfurt), S. Seseke(Diakonissenkrankenhaus), Lothar Bergmann(Universität Ulm), Peter J. Goebell(Friedrich-Alexander-Universität Erlangen-Nürnberg), Edwin Herrmann(St. Jude Children's Research Hospital), Sandra Steffens(Medizinische Hochschule Hannover), Christian Keil(Philipps University of Marburg), Steffen Weikert(St. Hedwig-Krankenhaus), Jan Roigas(Klinikum im Friedrichshain)
Cited by 12
Related Papers
The Epidemiology of Renal Cell Carcinoma
|European Urology|2011|1k
High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome
|Blood|1997|352
IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial
|The Lancet Oncology|2016|218
The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
|European Journal of Cancer|2010|187
Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients
|Clinical Cancer Research|2012|164